Agilon Health, Inc.
$96.58
The Read: Agilon Health’s stock surged over 210% after Q1 2026 results beat estimates and guidance was raised alongside a new CEO appointment, but then fell about 8% post-Q2 despite raised guidance as investors doubted the turnaround’s sustainability.
AGL
Hover to view data
No Data